Emergent BioSolutions to buy Sanofi ’s smallpox vaccine business for $125m

US-based Emergent BioSolutions has entered an agreement to buy the ACAM2000, smallpox vaccine business of French pharmaceutical company Sanofi for up to $125m.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news